Device type · CHL
Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
CHL
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
23
510(k), De Novo and PMA
Adverse event reports
181
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph
- Product code
- CHL
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1120
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for CHL
Latest FDA decisions
The 8 newest of 23 since 2015.
K252207 · Decided Apr 10, 2026 · 270 days after receipt
Device type: Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph (CHL) · Laboratory Medicine & Pathology
K244014 · Decided May 2, 2025 · 127 days after receipt
Device type: Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph (CHL) · Laboratory Medicine & Pathology
- ABL90 FLEX PLUS System510(k)
K240998 · Decided Dec 13, 2024 · 246 days after receipt
Device type: Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph (CHL) · Laboratory Medicine & Pathology
20 more FDA decisions with a free account
Reports received
181
Received Nov 1, 2025 to Nov 19, 2026. Includes 3 of another or unstated type.
Malfunction reports
172
95% of reports
Injury reports
1
0.6% of reports
Death reports
5
2.8% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 8 | 0 | 0 | 0 |
| Jan 24 | 9 | 0 | 0 | 0 |
| Feb 24 | 11 | 0 | 0 | 0 |
| Mar 24 | 18 | 0 | 0 | 0 |
| Apr 24 | 23 | 0 | 0 | 0 |
| May 24 | 16 | 1 | 0 | 0 |
| Jun 24 | 12 | 0 | 0 | 0 |
| Jul 24 | 15 | 0 | 0 | 0 |
| Aug 24 | 18 | 0 | 0 | 0 |
| Sep 24 | 22 | 3 | 0 | 0 |
| Oct 24 | 17 | 0 | 1 | 0 |
| Nov 24 | 14 | 0 | 0 | 0 |
| Dec 24 | 15 | 0 | 1 | 0 |
| Jan 25 | 20 | 0 | 0 | 0 |
| Feb 25 | 16 | 1 | 0 | 0 |
| Mar 25 | 33 | 0 | 0 | 0 |
| Apr 25 | 20 | 0 | 0 | 0 |
| May 25 | 24 | 0 | 0 | 0 |
| Jun 25 | 17 | 0 | 0 | 0 |
| Jul 25 | 24 | 0 | 2 | 0 |
| Aug 25 | 11 | 0 | 0 | 0 |
| Sep 25 | 12 | 1 | 1 | 0 |
| Oct 25 | 11 | 1 | 1 | 0 |
| Nov 25 | 7 | 0 | 1 | 0 |
| Dec 25 | 9 | 0 | 0 | 0 |
| Jan 26 | 12 | 0 | 0 | 0 |
| Feb 26 | 10 | 0 | 0 | 0 |
| Mar 26 | 31 | 0 | 0 | 0 |
| Apr 26 | 32 | 0 | 1 | 1 |
| May 26 | 12 | 0 | 0 | 0 |
| Jun 26 | 15 | 1 | 0 | 0 |
| Jul 26 | 12 | 0 | 0 | 0 |
| Aug 26 | 9 | 0 | 1 | 1 |
| Sep 26 | 13 | 0 | 2 | 1 |
| Oct 26 | 10 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Epocal31
7 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Low Test Results39
- Low Readings23
- High Readings22
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions159
- Insufficient Information15
- Needle Stick/Puncture2
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0190-2027 · Started Aug 18, 2026 · Posted by FDA Oct 15, 2026
Reason given: In vitro diagnostic analyzer had a risk of potentially inaccurate results requiring changes to instructions for use and: 1) Sample types, including whole blood samples no longer suitable for testing FHbF and ctBil, 2) Reportable ranges for some parameters, 3) Analyzer configuration, and 4) limitations and warnings.
Cause as FDA categorized it: No Marketing Application
Z-2899-2026 · Started May 21, 2026 · Posted by FDA Aug 6, 2026
Reason given: The active ingredient concentration in the lysing bag solution of specific GEM Premier 7000 with iQM3 PAK lots did not meet established manufacturing specifications. The malfunction could result in delayed recognition and management of Co-Oximetry and total bilirubin abnormalities and their sequelae.
Cause as FDA categorized it: Nonconforming Material/Component
- GEM Premier 5000 PAK Part Numbers: 00055360010 00055360011 00055407504 00055415010 00055430010 00055430011 00055445010 00055445011 00055360010.AOpen, Classified
Z-2900-2026 · Started May 21, 2026 · Posted by FDA Aug 6, 2026
Reason given: The active ingredient concentration in the lysing bag solution of specific GEM Premier 5000 lots did not meet established manufacturing specifications. The malfunction could result in delayed recognition and management of Co-Oximetry and total bilirubin abnormalities and their sequelae.
Cause as FDA categorized it: Nonconforming Material/Component
182 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.